FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.7  |  FHIR Version n/a  User: [n/a]

900000000000509007: United States of America English language reference set (foundation metadata concept)


Status: current, estado de definición de concepto necesario pero no suficiente (metadato del núcleo). Date: 31-Jan 2002. Module: módulo identificador para componentes del modelo de SNOMED CT (metadato del núcleo)

Descriptions:

Id Description Lang Type Status Case? Module
2911457018 conjunto de referencias de idioma inglés de acuerdo con la ortografía de Estados Unidos de Norteamérica es sinónimo (metadato del núcleo) Active letras mayúsculas y minúsculas relevantes en todo el término (metadato del núcleo) Latin American Spanish extension module
2911675011 conjunto de referencias de idioma inglés de acuerdo con la ortografía de Estados Unidos de Norteamérica (metadato fundacional) es descripción completa Active letras mayúsculas y minúsculas relevantes en todo el término (metadato del núcleo) Latin American Spanish extension module
2911702016 inglés estadounidense es sinónimo (metadato del núcleo) Active uso de mayúsculas y minúsculas sin relevancia para la totalidad del término (metadato del núcleo) Latin American Spanish extension module
900000000001115012 United States of America English language reference set en sinónimo (metadato del núcleo) Active letras mayúsculas y minúsculas relevantes en todo el término (metadato del núcleo) módulo identificador para componentes del modelo de SNOMED CT (metadato del núcleo)
900000000001116013 US English en sinónimo (metadato del núcleo) Active letras mayúsculas y minúsculas relevantes en todo el término (metadato del núcleo) módulo identificador para componentes del modelo de SNOMED CT (metadato del núcleo)
900000000001117016 United States of America English language reference set (foundation metadata concept) en descripción completa Active letras mayúsculas y minúsculas relevantes en todo el término (metadato del núcleo) módulo identificador para componentes del modelo de SNOMED CT (metadato del núcleo)


1321854 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
conjunto de referencias de idioma inglés de acuerdo con la ortografía de Estados Unidos de Norteamérica (metadato fundacional) es un[a] conjunto de referencias de lenguaje para el idioma inglés true relación inferida restricción existencial (metadato del núcleo)

Members acceptabilityId
pT2 category (finding) preferido
pT2 stage aceptable (metadato fundacional)
pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin) preferido
pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin) (finding) preferido
pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma) preferido
pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma) (finding) preferido
pT2: Organ confined (prostate) preferido
pT2: Organ confined (prostate) (finding) preferido
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm (liver, including intrahepatic bile ducts) preferido
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm (liver, including intrahepatic bile ducts) (finding) preferido
pT2: Tumor > 2 cm but <= 5 cm in greatest dimension (breast) aceptable (metadato fundacional)
pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus) preferido
pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus) (finding) preferido
pT2: Tumor confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma) preferido
pT2: Tumor confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma) (finding) preferido
pT2: Tumor extends to the soft tissues (nasopharynx) preferido
pT2: Tumor extends to the soft tissues (nasopharynx) (finding) preferido
pT2: Tumor extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis) preferido
pT2: Tumor extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis) (finding) preferido
pT2: Tumor extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis) preferido
pT2: Tumor extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis) (finding) preferido
pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma) preferido
pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma) (finding) preferido
pT2: Tumor invades beyond the wall of bile duct (extrahepatic bile ducts) preferido
pT2: Tumor invades beyond the wall of bile duct (extrahepatic bile ducts) (finding) preferido
pT2: Tumor invades duodenal wall (ampulla of Vater) preferido
pT2: Tumor invades duodenal wall (ampulla of Vater) (finding) preferido
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx) preferido
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx) (finding) preferido
pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx preferido
pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx (finding) preferido
pT2: Tumor invades muscularis (renal pelvis and ureter) preferido
pT2: Tumor invades muscularis (renal pelvis and ureter) (finding) preferido
pT2: Tumor invades muscularis propria (appendix) preferido
pT2: Tumor invades muscularis propria (appendix) (finding) preferido
pT2: Tumor invades muscularis propria (colon/rectum) preferido
pT2: Tumor invades muscularis propria (colon/rectum) (finding) preferido
pT2: Tumor invades muscularis propria (esophagus) preferido
pT2: Tumor invades muscularis propria (esophagus) (finding) preferido
pT2: Tumor invades muscularis propria (small intestine) preferido
pT2: Tumor invades muscularis propria (small intestine) (finding) preferido
pT2: Tumor invades muscularis propria (urinary bladder, ureter, renal pelvis) preferido
pT2: Tumor invades muscularis propria (urinary bladder, ureter, renal pelvis) (finding) preferido
pT2: Tumor invades muscularis propria or subserosa (stomach) preferido
pT2: Tumor invades muscularis propria or subserosa (stomach) (finding) preferido
pT2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver (gallbladder) preferido
pT2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver (gallbladder) (finding) preferido
pT2: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion (nasal cavity and ethmoid sinus) preferido
pT2: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion (nasal cavity and ethmoid sinus) (finding) preferido
pT2: Tumor involves any of the ipsilateral pleural surfaces with at least one of the following: confluent visceral pleural tumor (including fissure), invasion of diaphragmatic muscle, invasion of lung parenchyma (thoracic mesothelioma) preferido
pT2: Tumor involves any of the ipsilateral pleural surfaces with at least one of the following: confluent visceral pleural tumor (including fissure), invasion of diaphragmatic muscle, invasion of lung parenchyma (thoracic mesothelioma) (finding) preferido
pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension (exocrine pancreas) preferido
pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension (exocrine pancreas) (finding) preferido
pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis (testis) preferido
pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis (testis) (finding) preferido
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (lip and oral cavity) preferido
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (lip and oral cavity) (finding) preferido
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (oropharynx) preferido
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (oropharynx) (finding) preferido
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid) preferido
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid) (finding) preferido
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands) preferido
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands) (finding) preferido
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (anal canal) preferido
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (anal canal) (finding) preferido
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (breast) preferido
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (breast) (finding) preferido
pT2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) preferido
pT2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding) preferido
pT2: Tumor more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing sarcoma) aceptable (metadato fundacional)
pT2: Tumor more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) preferido
pT2: Tumor more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding) preferido
pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney (kidney) preferido
pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney (kidney) (finding) preferido
pT2: Tumor more than 8 cm in greatest dimension (bone) preferido
pT2: Tumor more than 8 cm in greatest dimension (bone) (finding) preferido
pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing sarcoma) aceptable (metadato fundacional)
pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) preferido
pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding) preferido
pT2: Tumor of lung as per AJCC 6th Edition definition (lung) preferido
pT2: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung) aceptable (metadato fundacional)
pT2: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung) (finding) preferido
pT2a (AJCC) preferido
pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) preferido
pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding) preferido
pT2a (IIA): Tumor involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube) preferido
pT2a (IIA): Tumor involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube) (finding) preferido
pT2a (IIA): Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) preferido
pT2a (IIA): Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) (finding) preferido
pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) preferido
pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) (finding) preferido
pT2a (UICC) preferido
pT2a category preferido
pT2a category (finding) preferido
pT2a1 (AJCC) preferido
pT2a1 (UICC) preferido
pT2a2 (AJCC) preferido
pT2a2 (UICC) preferido
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) preferido
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) (finding) preferido
pT2a: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) preferido

Start Previous Page 13200 of 13219 Next End


Reference Sets

Latin American Spanish language reference set

Chile language reference set (foundation metadata concept)

conjunto de referencias descriptivas de la estructura de otros conjuntos de referencias

Back to Start